We detected the sensitivity of different cell lines to chemotherapeutics drugs, and found that T47D cells, which represented luminal breast cancer, were resistant to the majority of chemotherapy drugs, while BT474, representative of the HER2+ breast cancer and MDA-MB-231 representative of basal-like breast cancer, were sensitive to paclitaxel. This evidence concerns the gene ERBB2 and breast carcinoma.